Immix Biopharma IMMX
NASDAQ IMMX
$8.66 +0.31 (+3.71%)
As of: Nov 11, 2026 · 3:59 PM EST

Immix Biopharma (IMMX) Minority Interest (2023 - 2024)

Updated

Immix Biopharma's Minority Interest came in at -$283,282 for Q1 2024, compared with -$32,358 a year earlier.

Analysis

Immix Biopharma (IMMX) Minority Interest (2023 - 2024) Analysis & Trends

At the end of FY2023, Immix Biopharma's Minority Interest was -$201,737.

  • Business Quant data shows IMMX's Minority Interest at -$201,737 (Q4 2023), -$124,667 (Q3 2023) and -$56,770 (Q2 2023) in the three quarters before Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Immix Biopharma 597.32 Mn 365.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -283,282.00
Dec 31, 2023 -201,737.00
Sep 30, 2023 -124,667.00
Jun 30, 2023 -56,770.00
Mar 31, 2023 -32,358.00
API Access

Immix Biopharma Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=IMMX&period=max&api_key=YOUR_API_KEY